Sponsor:
Taiho Oncology, Inc.
Code:
NCT07691606
Conditions
B-cell Non Hodgkin Lymphoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
ARC-02
Rituximab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-07-14. This information was provided to ClinicalTrials.gov by Taiho Oncology, Inc. on 2026-07-09.